Review



pna biotin  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Vector Laboratories pna biotin
    Pna Biotin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 143 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pna biotin/product/Vector Laboratories
    Average 93 stars, based on 143 article reviews
    pna biotin - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    Vector Laboratories pna biotin
    Pna Biotin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pna biotin/product/Vector Laboratories
    Average 93 stars, based on 1 article reviews
    pna biotin - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Vector Laboratories vva biotin
    Overview of the study of GalNAc-type O-glycosylation in neuronal tissues. A , schematic of common O-glycan structures found in the mammalian brain . The most abundant di-sialyl-T (DiST) structure is biosynthesized from the underlying Core one structure. Only a minor fraction of the Core two structure was reported. A combination of desialylation (Neu) and Core 1- (Jacalin and Peanut agglutinin, PNA) or Tn- ( Vicia villosa , <t>VVA)</t> <t>binding</t> <t>lectins</t> was used to enrich for tryptic glycopeptides subjected to our glycoproteomic workflow (Sfig 1A). B , Bar graph displaying the number of glycoproteins and glycosites identified from individual biosources across species. C , overview of the expanded neuronal glycoproteome built by consolidating human O-glycosites with animal sites that are conserved in human proteins by orthologue sequence alignment (3389 sites). Sequence alignment was performed using ClustalO on the full-length sequence of each animal glycoprotein and its human orthologue. Glycosites that aligned to Ser/Thr/Tyr were included in the expanded neuronal glycoproteome (4228) ( bottom ). Proportion of human sites, expanding sites and total number of sites predicted by the Net-O-Glyc 4.0 algorithm are stated in parentheses. D , species source overlap among the total 4228 O-glycosites of the expanded dataset. E , the expanded neuronal O-glycoproteome contributes novel O-glycosites compared to the current aggregate of experimentally identified human O-glycosites ( yellow ) ( https://glyco.me/docs/resources/glycodomain/ ). The proportion of sites that are experimentally verified in human samples is given in parentheses.
    Vva Biotin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vva biotin/product/Vector Laboratories
    Average 93 stars, based on 1 article reviews
    vva biotin - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Vector Laboratories biotin conjugated vva
    Overview of the study of GalNAc-type O-glycosylation in neuronal tissues. A , schematic of common O-glycan structures found in the mammalian brain . The most abundant di-sialyl-T (DiST) structure is biosynthesized from the underlying Core one structure. Only a minor fraction of the Core two structure was reported. A combination of desialylation (Neu) and Core 1- (Jacalin and Peanut agglutinin, PNA) or Tn- ( Vicia villosa , <t>VVA)</t> <t>binding</t> <t>lectins</t> was used to enrich for tryptic glycopeptides subjected to our glycoproteomic workflow (Sfig 1A). B , Bar graph displaying the number of glycoproteins and glycosites identified from individual biosources across species. C , overview of the expanded neuronal glycoproteome built by consolidating human O-glycosites with animal sites that are conserved in human proteins by orthologue sequence alignment (3389 sites). Sequence alignment was performed using ClustalO on the full-length sequence of each animal glycoprotein and its human orthologue. Glycosites that aligned to Ser/Thr/Tyr were included in the expanded neuronal glycoproteome (4228) ( bottom ). Proportion of human sites, expanding sites and total number of sites predicted by the Net-O-Glyc 4.0 algorithm are stated in parentheses. D , species source overlap among the total 4228 O-glycosites of the expanded dataset. E , the expanded neuronal O-glycoproteome contributes novel O-glycosites compared to the current aggregate of experimentally identified human O-glycosites ( yellow ) ( https://glyco.me/docs/resources/glycodomain/ ). The proportion of sites that are experimentally verified in human samples is given in parentheses.
    Biotin Conjugated Vva, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin conjugated vva/product/Vector Laboratories
    Average 93 stars, based on 1 article reviews
    biotin conjugated vva - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Vector Laboratories biotin vicia villosa lectin
    Overview of the study of GalNAc-type O-glycosylation in neuronal tissues. A , schematic of common O-glycan structures found in the mammalian brain . The most abundant di-sialyl-T (DiST) structure is biosynthesized from the underlying Core one structure. Only a minor fraction of the Core two structure was reported. A combination of desialylation (Neu) and Core 1- (Jacalin and Peanut agglutinin, PNA) or Tn- ( Vicia villosa , <t>VVA)</t> <t>binding</t> <t>lectins</t> was used to enrich for tryptic glycopeptides subjected to our glycoproteomic workflow (Sfig 1A). B , Bar graph displaying the number of glycoproteins and glycosites identified from individual biosources across species. C , overview of the expanded neuronal glycoproteome built by consolidating human O-glycosites with animal sites that are conserved in human proteins by orthologue sequence alignment (3389 sites). Sequence alignment was performed using ClustalO on the full-length sequence of each animal glycoprotein and its human orthologue. Glycosites that aligned to Ser/Thr/Tyr were included in the expanded neuronal glycoproteome (4228) ( bottom ). Proportion of human sites, expanding sites and total number of sites predicted by the Net-O-Glyc 4.0 algorithm are stated in parentheses. D , species source overlap among the total 4228 O-glycosites of the expanded dataset. E , the expanded neuronal O-glycoproteome contributes novel O-glycosites compared to the current aggregate of experimentally identified human O-glycosites ( yellow ) ( https://glyco.me/docs/resources/glycodomain/ ). The proportion of sites that are experimentally verified in human samples is given in parentheses.
    Biotin Vicia Villosa Lectin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin vicia villosa lectin/product/Vector Laboratories
    Average 93 stars, based on 1 article reviews
    biotin vicia villosa lectin - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Vector Laboratories vicia villosa biotin vva
    Overview of the study of GalNAc-type O-glycosylation in neuronal tissues. A , schematic of common O-glycan structures found in the mammalian brain . The most abundant di-sialyl-T (DiST) structure is biosynthesized from the underlying Core one structure. Only a minor fraction of the Core two structure was reported. A combination of desialylation (Neu) and Core 1- (Jacalin and Peanut agglutinin, PNA) or Tn- ( Vicia villosa , <t>VVA)</t> <t>binding</t> <t>lectins</t> was used to enrich for tryptic glycopeptides subjected to our glycoproteomic workflow (Sfig 1A). B , Bar graph displaying the number of glycoproteins and glycosites identified from individual biosources across species. C , overview of the expanded neuronal glycoproteome built by consolidating human O-glycosites with animal sites that are conserved in human proteins by orthologue sequence alignment (3389 sites). Sequence alignment was performed using ClustalO on the full-length sequence of each animal glycoprotein and its human orthologue. Glycosites that aligned to Ser/Thr/Tyr were included in the expanded neuronal glycoproteome (4228) ( bottom ). Proportion of human sites, expanding sites and total number of sites predicted by the Net-O-Glyc 4.0 algorithm are stated in parentheses. D , species source overlap among the total 4228 O-glycosites of the expanded dataset. E , the expanded neuronal O-glycoproteome contributes novel O-glycosites compared to the current aggregate of experimentally identified human O-glycosites ( yellow ) ( https://glyco.me/docs/resources/glycodomain/ ). The proportion of sites that are experimentally verified in human samples is given in parentheses.
    Vicia Villosa Biotin Vva, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vicia villosa biotin vva/product/Vector Laboratories
    Average 93 stars, based on 1 article reviews
    vicia villosa biotin vva - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Vector Laboratories biotin conjugated vicia villosa lectin
    Overview of the study of GalNAc-type O-glycosylation in neuronal tissues. A , schematic of common O-glycan structures found in the mammalian brain . The most abundant di-sialyl-T (DiST) structure is biosynthesized from the underlying Core one structure. Only a minor fraction of the Core two structure was reported. A combination of desialylation (Neu) and Core 1- (Jacalin and Peanut agglutinin, PNA) or Tn- ( Vicia villosa , <t>VVA)</t> <t>binding</t> <t>lectins</t> was used to enrich for tryptic glycopeptides subjected to our glycoproteomic workflow (Sfig 1A). B , Bar graph displaying the number of glycoproteins and glycosites identified from individual biosources across species. C , overview of the expanded neuronal glycoproteome built by consolidating human O-glycosites with animal sites that are conserved in human proteins by orthologue sequence alignment (3389 sites). Sequence alignment was performed using ClustalO on the full-length sequence of each animal glycoprotein and its human orthologue. Glycosites that aligned to Ser/Thr/Tyr were included in the expanded neuronal glycoproteome (4228) ( bottom ). Proportion of human sites, expanding sites and total number of sites predicted by the Net-O-Glyc 4.0 algorithm are stated in parentheses. D , species source overlap among the total 4228 O-glycosites of the expanded dataset. E , the expanded neuronal O-glycoproteome contributes novel O-glycosites compared to the current aggregate of experimentally identified human O-glycosites ( yellow ) ( https://glyco.me/docs/resources/glycodomain/ ). The proportion of sites that are experimentally verified in human samples is given in parentheses.
    Biotin Conjugated Vicia Villosa Lectin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin conjugated vicia villosa lectin/product/Vector Laboratories
    Average 93 stars, based on 1 article reviews
    biotin conjugated vicia villosa lectin - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Vector Laboratories biotin conjugated lectin vva
    Overview of the study of GalNAc-type O-glycosylation in neuronal tissues. A , schematic of common O-glycan structures found in the mammalian brain . The most abundant di-sialyl-T (DiST) structure is biosynthesized from the underlying Core one structure. Only a minor fraction of the Core two structure was reported. A combination of desialylation (Neu) and Core 1- (Jacalin and Peanut agglutinin, PNA) or Tn- ( Vicia villosa , <t>VVA)</t> <t>binding</t> <t>lectins</t> was used to enrich for tryptic glycopeptides subjected to our glycoproteomic workflow (Sfig 1A). B , Bar graph displaying the number of glycoproteins and glycosites identified from individual biosources across species. C , overview of the expanded neuronal glycoproteome built by consolidating human O-glycosites with animal sites that are conserved in human proteins by orthologue sequence alignment (3389 sites). Sequence alignment was performed using ClustalO on the full-length sequence of each animal glycoprotein and its human orthologue. Glycosites that aligned to Ser/Thr/Tyr were included in the expanded neuronal glycoproteome (4228) ( bottom ). Proportion of human sites, expanding sites and total number of sites predicted by the Net-O-Glyc 4.0 algorithm are stated in parentheses. D , species source overlap among the total 4228 O-glycosites of the expanded dataset. E , the expanded neuronal O-glycoproteome contributes novel O-glycosites compared to the current aggregate of experimentally identified human O-glycosites ( yellow ) ( https://glyco.me/docs/resources/glycodomain/ ). The proportion of sites that are experimentally verified in human samples is given in parentheses.
    Biotin Conjugated Lectin Vva, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin conjugated lectin vva/product/Vector Laboratories
    Average 93 stars, based on 1 article reviews
    biotin conjugated lectin vva - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Overview of the study of GalNAc-type O-glycosylation in neuronal tissues. A , schematic of common O-glycan structures found in the mammalian brain . The most abundant di-sialyl-T (DiST) structure is biosynthesized from the underlying Core one structure. Only a minor fraction of the Core two structure was reported. A combination of desialylation (Neu) and Core 1- (Jacalin and Peanut agglutinin, PNA) or Tn- ( Vicia villosa , VVA) binding lectins was used to enrich for tryptic glycopeptides subjected to our glycoproteomic workflow (Sfig 1A). B , Bar graph displaying the number of glycoproteins and glycosites identified from individual biosources across species. C , overview of the expanded neuronal glycoproteome built by consolidating human O-glycosites with animal sites that are conserved in human proteins by orthologue sequence alignment (3389 sites). Sequence alignment was performed using ClustalO on the full-length sequence of each animal glycoprotein and its human orthologue. Glycosites that aligned to Ser/Thr/Tyr were included in the expanded neuronal glycoproteome (4228) ( bottom ). Proportion of human sites, expanding sites and total number of sites predicted by the Net-O-Glyc 4.0 algorithm are stated in parentheses. D , species source overlap among the total 4228 O-glycosites of the expanded dataset. E , the expanded neuronal O-glycoproteome contributes novel O-glycosites compared to the current aggregate of experimentally identified human O-glycosites ( yellow ) ( https://glyco.me/docs/resources/glycodomain/ ). The proportion of sites that are experimentally verified in human samples is given in parentheses.

    Journal: The Journal of Biological Chemistry

    Article Title: Map of the neuronal O-glycoproteome reveals driver functions in the regulated secretory pathway

    doi: 10.1016/j.jbc.2025.110313

    Figure Lengend Snippet: Overview of the study of GalNAc-type O-glycosylation in neuronal tissues. A , schematic of common O-glycan structures found in the mammalian brain . The most abundant di-sialyl-T (DiST) structure is biosynthesized from the underlying Core one structure. Only a minor fraction of the Core two structure was reported. A combination of desialylation (Neu) and Core 1- (Jacalin and Peanut agglutinin, PNA) or Tn- ( Vicia villosa , VVA) binding lectins was used to enrich for tryptic glycopeptides subjected to our glycoproteomic workflow (Sfig 1A). B , Bar graph displaying the number of glycoproteins and glycosites identified from individual biosources across species. C , overview of the expanded neuronal glycoproteome built by consolidating human O-glycosites with animal sites that are conserved in human proteins by orthologue sequence alignment (3389 sites). Sequence alignment was performed using ClustalO on the full-length sequence of each animal glycoprotein and its human orthologue. Glycosites that aligned to Ser/Thr/Tyr were included in the expanded neuronal glycoproteome (4228) ( bottom ). Proportion of human sites, expanding sites and total number of sites predicted by the Net-O-Glyc 4.0 algorithm are stated in parentheses. D , species source overlap among the total 4228 O-glycosites of the expanded dataset. E , the expanded neuronal O-glycoproteome contributes novel O-glycosites compared to the current aggregate of experimentally identified human O-glycosites ( yellow ) ( https://glyco.me/docs/resources/glycodomain/ ). The proportion of sites that are experimentally verified in human samples is given in parentheses.

    Article Snippet: Subsequently, blots were incubated O/N using the following lectins or antibodies: VVA-Biotin 1:2000 (Vector-labs, B-1235–2), PNA-Biotin 1:2000 (Vector-labs, B-1075–5), Anti-CHGA 1:1000 (AbCam, Ab15160), Anti-CS 1:1000 (Abcam, ab11570), Anti-B-actin 1:10.000 (Protein Tech, 66009-1-Ig), anti-CHGB (Abcam, ab12242) or anti-VGF (Abcam, ab69989).

    Techniques: Glycoproteomics, Binding Assay, Sequencing

    Probing roles of elaborate O-glycans for regulated secre tion . A , targeting C1GALT1 enzyme or its obligate private COSMC chaperone by CRISPR-Cas9 results in SC cells producing truncated (Tn) O-glycans on proteins. B , representative immunofluorescence images of STC-1 and SH-SY5Y WT and SC cells. Pretreatment with neuraminidase shows the gain of Tn (VVA) and loss of Core 1 (PNA) in SCs and validates the glycoengineering. C and D , Western blot analysis of secretomes ± depolarization from SH-SY5Y and STC-1 WT and SC cells. Blots were pretreated with neuraminidase and probed with the VVA lectin to selectively identify O-glycoproteins with truncated Tn O-glycans. Arrows indicate relative migration of highly glycosylated granins (deferred from separate western blots (Sfig 2C)). A VVA-reactive smear that co-mobilizes with both chondroitin sulfate and high molecular weight CHGA is indicated by a grey arrow . Asterisks (∗) denote background bands. E , Bar plot showing the mean relative secretion of the KCl-responsive proteins in SH-SY5Y WT and ΔCOSMC (SH-SY5Y SC ). Error bars represent + standard error of the mean, n = 5 clones.

    Journal: The Journal of Biological Chemistry

    Article Title: Map of the neuronal O-glycoproteome reveals driver functions in the regulated secretory pathway

    doi: 10.1016/j.jbc.2025.110313

    Figure Lengend Snippet: Probing roles of elaborate O-glycans for regulated secre tion . A , targeting C1GALT1 enzyme or its obligate private COSMC chaperone by CRISPR-Cas9 results in SC cells producing truncated (Tn) O-glycans on proteins. B , representative immunofluorescence images of STC-1 and SH-SY5Y WT and SC cells. Pretreatment with neuraminidase shows the gain of Tn (VVA) and loss of Core 1 (PNA) in SCs and validates the glycoengineering. C and D , Western blot analysis of secretomes ± depolarization from SH-SY5Y and STC-1 WT and SC cells. Blots were pretreated with neuraminidase and probed with the VVA lectin to selectively identify O-glycoproteins with truncated Tn O-glycans. Arrows indicate relative migration of highly glycosylated granins (deferred from separate western blots (Sfig 2C)). A VVA-reactive smear that co-mobilizes with both chondroitin sulfate and high molecular weight CHGA is indicated by a grey arrow . Asterisks (∗) denote background bands. E , Bar plot showing the mean relative secretion of the KCl-responsive proteins in SH-SY5Y WT and ΔCOSMC (SH-SY5Y SC ). Error bars represent + standard error of the mean, n = 5 clones.

    Article Snippet: Subsequently, blots were incubated O/N using the following lectins or antibodies: VVA-Biotin 1:2000 (Vector-labs, B-1235–2), PNA-Biotin 1:2000 (Vector-labs, B-1075–5), Anti-CHGA 1:1000 (AbCam, Ab15160), Anti-CS 1:1000 (Abcam, ab11570), Anti-B-actin 1:10.000 (Protein Tech, 66009-1-Ig), anti-CHGB (Abcam, ab12242) or anti-VGF (Abcam, ab69989).

    Techniques: CRISPR, Immunofluorescence, Western Blot, Migration, High Molecular Weight, Clone Assay